Multimedia

July 29, 2017
References
  1. AskMayoExpert. Esophageal and gastric cancer. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  2. Niederhuber JE, et al., eds. Cancer of the stomach and gastroesophageal junction. In: Abeloff 's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. https://www.clinicalkey.com. Accessed March 23, 2016.
  3. Feldman M, et al. Adenocarcinoma of the stomach and other gastric tumors. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 10th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. https://www.clinicalkey.com. Accessed March 23, 2016.
  4. Gastric cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed March 23, 2016.
  5. Gastrointestinal stromal tumors treatment — Patient version (PDQ). National Cancer Institute. http://www.cancer.gov/types/soft-tissue-sarcoma/patient/gist-treatment-pdq. Accessed March 24, 2016.
  6. Palliative care. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed March 23, 2016.
  7. Singh S, et al. Physical activity is associated with reduced risk of gastric cancer: A systematic review and meta-analysis. Cancer Prevention Research. 2014;7:12.
  8. Carr JS, et al. Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma. Journal of Gastrointestinal Cancer. 2013;44:143.
  9. Atasoy A, et al. Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas. https://www.uptodate.com/home. Accessed April 26, 2017.
  10. Goode EF, et al. Immunotherapy for gastroesophageal cancer. Journal of Clinical Medicine. 2016;5:84.
  11. Crane SJ, et al. Subsite-specific risk factors for esophageal and gastric adenocarcinoma. American Journal of Gastroenterology. 2007;102:1596.
  12. Ajanai JA, et al. Esophageal and esophagogastric junction cancers, version 1.2015. Journal of the National Comprehensive Cancer Network. 2015;13:194.
  13. Maron SB, et al. Novel targeted therapies for esophagogastric cancer. Surgical Oncology Clinics of North America. 2017;26:293.